These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7675453)
1. Deregulation of cyclin E in breast cancer. Keyomarsi K; Conte D; Toyofuku W; Fox MP Oncogene; 1995 Sep; 11(5):941-50. PubMed ID: 7675453 [TBL] [Abstract][Full Text] [Related]
2. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells. Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL; Buffolino P; Kopman C; Nathanson L Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260 [TBL] [Abstract][Full Text] [Related]
4. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S; Lowe M; Herliczek TW; Keyomarsi K Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049 [TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G; Hunter T; Ruoslahti E Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134 [TBL] [Abstract][Full Text] [Related]
7. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells. Park US; Park SK; Lee YI; Park JG; Lee YI Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595 [TBL] [Abstract][Full Text] [Related]
9. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A; Washington Parks R; Rivadeneira E; Franchini G Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195 [TBL] [Abstract][Full Text] [Related]
10. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines. Crowe DL; Shuler CF Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179 [TBL] [Abstract][Full Text] [Related]
11. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236 [TBL] [Abstract][Full Text] [Related]
12. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Wu G; Fan RS; Li W; Ko TC; Brattain MG Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407 [TBL] [Abstract][Full Text] [Related]
13. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932 [TBL] [Abstract][Full Text] [Related]
14. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Neve RM; Sutterlüty H; Pullen N; Lane HA; Daly JM; Krek W; Hynes NE Oncogene; 2000 Mar; 19(13):1647-56. PubMed ID: 10763821 [TBL] [Abstract][Full Text] [Related]
15. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence. Kanazawa S; Fujiwara Y; Mizuno K Kobe J Med Sci; 1994 Dec; 40(5-6):165-74. PubMed ID: 7542356 [TBL] [Abstract][Full Text] [Related]
16. Formation of p27-CDK complexes during the human mitotic cell cycle. Soos TJ; Kiyokawa H; Yan JS; Rubin MS; Giordano A; DeBlasio A; Bottega S; Wong B; Mendelsohn J; Koff A Cell Growth Differ; 1996 Feb; 7(2):135-46. PubMed ID: 8822197 [TBL] [Abstract][Full Text] [Related]
17. [Detection of cell cycle related gene expression in cultured immortalized human lens epithelial cell]. Wu M; Li S; Zeng J; Gao J; Liu Y Zhonghua Yan Ke Za Zhi; 2002 Jun; 38(6):367-71. PubMed ID: 12139816 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of G1/S cell cycle mediators in cellular senescence. Afshari CA; Vojta PJ; Annab LA; Futreal PA; Willard TB; Barrett JC Exp Cell Res; 1993 Dec; 209(2):231-7. PubMed ID: 8262140 [TBL] [Abstract][Full Text] [Related]
19. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Zariwala M; Liu J; Xiong Y Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943 [TBL] [Abstract][Full Text] [Related]
20. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2. Nakshatri H; Mendonca MS; Bhat-Nakshatri P; Patel NM; Goulet RJ; Cornetta K Biochem Biophys Res Commun; 2000 Apr; 270(3):1144-53. PubMed ID: 10772965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]